AC-262536 is a selective and non-steroidal androgen receptor modulators (SARMs) with beneficial anabolic effects. AC-262536 exhibits potent agonist activity at the androgen receptor, with an affinity in the low nanomolar range (1-10 nM).
体外研究
AC-262536 dose-dependently inhibits dihydroxytestosterone (DHT)-induced proliferation of LNCaP. The effects are significant with 100 nM AC-262536 (%inhibition 47.2±12.2), and reaches a plateau with 1 μM treatment (%inhibition 50.7±7.6). Thus, AC-262536 can act as a functional antagonist in prostate cells.
体内研究
AC-262536 (3, 10, 30 mg/kg) reverses the luteinizing hormone (LH) spike in castrated rats.
Animal Model:
Male Sprague-Dawley rats (200-225 g)
Dosage:
3, 10 and 30 mg/kg
Administration:
Administered subcutaneously; once daily for 14 consecutive days
Result:
Significantly decreased LH levels by about 40% at the 3 mg/kg dose.
The ED50 was determined to be 2.8 mg/kg.
At the 10 and 30 mg/kg doses, the effects of AC-262536 were significantly stronger than Testosterone Propionate (TP) : 1.91±0.32 ng/mL and 1.53±0.34 ng/mL vs. 3.12±0.69 ng/mL, respectively.
分子式
C18H18N2O
分子量
278.35
CAS号
870888-46-3
运输条件
Room temperature in continental US; may vary elsewhere.